MedTrace Logo

Prospective Cohort Study of Intravenous Lipid Emulsion for Resuscitating Critically-ill Poisoned Patients

NCT03107689 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 134

Last updated 2024-03-01

No results posted yet for this study

Summary

The purpose of this project is to evaluate the case characteristics of patients who receive intravenous lipid emulsion therapy. Previous literature to date has focused on animal studies or has been primarily limited to case reports or small case series. This prospectively collected data set will permit a much more detailed description of the use of lipid, its potential benefits, and potential harms.

Conditions

Interventions

OTHER

administration of intravenous lipid emulsion

all patients receive intravenous lipid emulsion at the discretion of the treating provider. This registry prospectively collects detailed information on such patients

Sponsors & Collaborators

  • American College of Medical Toxicology

    collaborator OTHER

  • University of Southern California

    lead OTHER

Principal Investigators

  • michael levine, md · University of Southern California

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03107689 on ClinicalTrials.gov